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Abstract
Background: Although there is abundant evidence that human longevity is heritable, efforts to map loci responsible for
variation in human lifespan have had limited success.
Methodology/Principal Findings: We identified individuals from a large multigenerational population database (the Utah
Population Database) who exhibited high levels of both familial longevity and individual longevity. This selection identified
325 related ‘‘affected individuals’’, defined as those in the top quartile for both excess longevity (EL=observed lifespan –
expected lifespan) and familial excess longevity (FEL=weighted average EL across all relatives). A whole-genome scan for
genetic linkage was performed on this sample using a panel of 1100 microsatellite markers. A strongly suggestive peak
(Z=4.2, Monte Carlo-adjusted p-value 0.09) was observed in the vicinity of D3S3547 on chromosome 3p24.1, at a point
nearly identical to that reported recently by an independent team of researchers from Harvard Medical School (HMS) [1].
Meta-analysis of linkage scores on 3p from the two studies produced a minimum nominal p-value of 1.005610
29 at 55 cM.
Other potentially noteworthy peaks in our data occur on 18q23-24, 8q23, and 17q21. Meta-analysis results from combined
UPDB and HMS data yielded additional support, but not formal replication, for linkage on 8q, 9q, and 17q.
Conclusions/Significance: Corroboration of the linkage of exceptional longevity to 3p22-24 greatly strengthens the case
that genes in this region affect variation in longevity and suggest, therefore, an important role in the regulation of human
lifespan. Future efforts should include intensive study of the 3p22-24 region.
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Introduction
It has long been thought that related individuals share a familial
predisposition to longevity, and for more than a century numerous
studies have investigated the degree to which human longevity
might be an inherited characteristic [2–12]. Most studies of this
type have reported small (,10%) to moderate (,30%) heritability
of human longevity, amid differences in definitions of longevity,
methods of measuring it, ascertaining individuals who demonstrate
it, and in various behavioral and environmental settings. These
methodological differences likely account for much of the variation
in the resulting estimates of the heritability of longevity.
To date the most intensive genome-wide scans for markers
associated with human longevity have been based on data
collected by the New England Centenarian Study (NECS). Puca
et al. first reported results of a sib-pair linkage study using a whole-
genome scan (308 subjects genotyped with 400 microsatellite
markers) in 2001 [13]. Later Boyden and Kunkel [1] produced an
updated sib pair linkage analysis using an expanded dataset (632
subjects, consisting of some of the NECS subjects and additional
subjects recruited more recently) along with a high-density panel
of 10,000 single nucleotide polymorphism (SNP) markers.
Lunetta and colleagues published a genome-wide association
study (GWAS) of longevity among Framingham Study participants
[14]. Despite numerous suggestive associations, Lunetta, et al.
turned up no significant results based on their genome-wide SNP
panel (of 100,000 markers). More recently, the Cohorts for Heart
and Aging Research in Genomic Epidemiology (CHARGE)
Consortium published a meta-analysis based on data from
Framingham and three other cohort studies (the Age, Gene/
Environment Susceptibility-Reykjavik Study, the Cardiovascular
Health Study, and the Rotterdam Study); a confirmatory second
stage genotyping included two additional datasets: the Leiden
Longevity Study and the Danish 1905 cohort [15]. Combining
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the meta-analysis over the 6 studies also failed to identify variants
of genome-wide significance after adjusting for multiple compar-
isons. Nebel, et al. [16] conducted a GWAS for a sample of 763
Germans ranging in age from 94 to 110 years old, with a mean age
99.7 years; 1085 controls were drawn for the study, aged 45–77
years old, with a mean age of 60.2 years. After adjusting for
662,472 comparisons and post hoc quality control assessments, 16
SNPs were identified for confirmatory testing in an independent
sample of 754 long-lived Germans and 860 controls. One SNP,
rs4420638 near APOC1, exhibited a significant association with
longevity both in the original and confirmatory tests. However,
this SNP (rs4420638) is only 14 kb from the APOE locus; it is in
strong linkage disequlibrium (LD) with the APOE e4 allele; and it
has long been known that APOE e4 is associated with all-cause
mortality [17]. Another recent GWAS study included 410 long-
lived individuals and 553 younger controls from southern Italy
[18]. In this study, the minor allele of one SNP (rs10491334) in the
gene CAMKIV, was associated with reduced CAMKIV expression,
and was underrepresented among long-lived individuals. CAMKIV
appears to activate the proteins AKT, SIRT1, and FOX03A, all of
which have been associated with increased longevity or longevity-
associated mechanisms in humans and several model organisms
[19–21].
GWAS studies of longevity must overcome several important
challenges. The need to control for a very large number of
comparisons compromises power considerably. The studies cited
above are all quite small by current GWAS standards, and
therefore, have only limited power to identify alleles associated
with longevity. Selection of appropriate controls is a particular
problem for studies of longevity. Controls are typically selected
from the current population according to study design, and are by
definition born one or more generations later than the long-lived
individuals to which they are compared. Under such circumstanc-
es, selection, drift, and migration can affect allele frequencies in
ways that might bias intergenerational GWAS results. Additional
and potentially more substantial biases can result from behavioral
changes across generations and time. Larger and more robust
GWASs will undoubtedly contribute importantly to our under-
standing of the genetics of longevity; but for now, other
approaches, including family studies, remain competitive.
Here we report the results of the Fertility, Longevity and Aging
(FLAG) study, a genome-wide genetic linkage study of familial
exceptional longevity. Subjects were selected from the Utah
Population Database [22,23] under a design that differs from most
others in several important characteristics: 1) subjects were
selected on the basis of both individual longevity, and a strong
family history of longevity; 2) relatives of varying degrees of
relationship were included; and 3) linkage analysis was based on a
microsatellite marker set (deCODE Genetics 1100 marker set)
more appropriate than a conventional 400 marker linkage panel to
the extended family structures of subjects drawn from the UPDB,
and hence, relatively short regions of identity by descent.
Methods
Utah Population Database
The Utah Population Database (UPDB) is a repository of
longitudinal information on Utahans and their families. Originally
constructed from genealogical data [23], the database has
developed by successive record linking to integrate cancer registry
data, Utah death certificates, U.S. Census data, Utah birth
certificates, Utah driver license records, and more recently,
medical records data. Currently the database includes information
pertaining to approximately 7 million individuals, many of whom
are integrated into multigenerational pedigree networks 2 to 14
generations deep [22].
Subjects
In two previous studies, we examined the influence of family
history on longevity in the UPDB: we defined excess longevity (EL)a s
the difference between observed and expected lifespan for an
individual; and we defined familial excess longevity (FEL) as a kinship-
weighted average of EL across all the family members of a subject
[11,12]. For this study, subjects were identified after evaluating
several methods for selecting them, using simulated data and
various combinations of EL and FEL. The goal was to maximize
the positive predictive value (the probability that a subject carried
a simulated longevity extending allele, given lower all-cause
mortality) while maximizing potential sample size.
Simulations assumed a genetic variant with autosomal domi-
nant inheritance, and an allele frequency of 0.01. Penetrance was
expressed as an all-cause mortality hazard ratio, and set at 0.5.
Although we considered multiple approaches to selecting subjects
based on individual longevity and family longevity scores,
including Markov chain Monte Carlo approaches, we found that
simply combining top quartile values of both EL and FEL
(EL$3.0; FEL$1.75) outperformed the other methods and was
simpler to administer. Simulation tests under different assumptions
about allele frequency and penetrance altered the sensitivity and
positive predictive value of the selection criteria, but did not
change the relative performance of the methods.
The University of Utah Health Sciences Institutional Review
Board and the University of Louisville Biomedical Institutional
Review Board approved the study protocol; all recruited subjects
provided their written consent to be included in this study. A total
of 732 study subjects were genotyped by deCODE Genetics,
Reykjavik, Iceland. Of these, 433 were identified as expressing an
excess longevity phenotype (ELP), and were considered ‘‘affected’’.
We recruited and genotyped 139 offspring of affected individuals,
and considered these putative carriers of the ELP. Last, we
recruited and genotyped 160 ‘‘controls’’: 54 offspring of deceased
siblings of ‘‘affected’’ individuals were considered putative non-
carriers of the long-lived phenotype; and106 randomly drawn
individuals from the UPDB population complete the control
group. Ages of the 433 ELP affected individuals ranged from 86 to
109 years old. Only 325 of these were related to another
genotyped affected individual. Subjects were enrolled between
August 2003 and January 2009. By 2009, 117 ELP affected
subjects had died. The total number of affected pairs over all
classes of relatives was 607, because many affected individuals
were related to multiple others through multiple lines of descent.
The complex and overlapping nature of the genealogical data
makes delineation of discrete ‘‘families’’ difficult: by the broadest
definition, all study subjects could be connected to one another by
one or more known genealogical links (including marriage). On
the other hand, the vast majority of affected pairs had kinship
values of zero, i.e. they were not biologically related by any known
common ancestry. In spite of the genealogical complexity, no
affected individual was measurably inbred.
Table 1 gives the demographic characteristics of study subjects.
The unexpected relative excess of males is explained by two
factors: first, the computation of excess longevity adjusts for sex,
effectively counting males as females approximately two years
older. Second, and more importantly, it proved easier to locate
extremely aged men, by current residence, than women in Utah.
Women in the UPDB are more likely to have changed their names
as a result of marriage, are less likely to have driver’s licenses
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billing records in their own names than are men. All these
characteristics make it more difficult to find a correct current
residence using the available records.
Genotypes
Genotyping was performed at deCODE Genetics, Reykjavik,
Iceland, using the deCODE 1100 microsatellite marker set. Here
we report only the autosomal marker results. Any marker
successfully typed in at least 50% of subjects was analyzed. The
maximum number of markers successfully typed in any sample
was 1074, and 1051 markers (97.8%) met the analysis inclusion
criterion (returned types for .50% of subjects). The number of
alleles observed per marker ranged from 2 (D9S1152, DG19S135)
to 38 (DG19S265). Average marker spacing over the 22 autosomes
was 3.4 cM. Allele frequencies were estimated from control
subjects by simple counting, and checked against the HapMap
European Reference (CEU) allele frequencies.
Analytical methods
The relatively large and complex sample – in particular the
large number of ungenotyped individuals intervening in the paths
of relationship between genotyped affected family members –
presented an analytical challenge. It proved impossible with
existing software to obtain reliable estimates of identity by descent
(IBD) probabilities. Exact estimation with software such as
Genehunter [24], Allegro [25], or Merlin [26] required more
computer memory than was available; Markov chain Monte Carlo
(MCMC) methods, as employed by Loki [27], Genibd [28],
SOLAR [29], and SIMWALK [30] failed to converge or
converged to obviously incorrect solutions, after consuming
literally weeks of CPU time.
Therefore, we used a simplified version of the venerable affected
pedigree member (APM) test, originally devised by Weeks and
Lange [31], as a primary test for linkage of EL to each
chromosomal region. Let Gi1 and Gi2 represent the two alleles of
a given marker carried by person i; Gj1 and Gj2 are the
corresponding alleles carried by a family member j of person i,
and q(g) is the allele frequency for marker allele g. Then the
sharing statistic Sij is:
Sij~w1d Gi1,Gj1

zw1d Gi1,Gj2

zw2d Gi2,Gj1

Izw2d Gi2,Gj2

,
wx~1=sqrt q Gix ðÞ ðÞ ,
where d is the Kronecker delta function (1 if the two arguments are
equal, 0 otherwise).
The APM statistic is the sum of the random variable Sij over all i
and j. As a test for significance, a null distribution of marker alleles
was generated using a ‘‘gene-dropping’’ algorithm: first alleles are
randomly assigned to founders in proportion to their expected
frequency; then they are transmitted by descent throughout the
pedigree. Five hundred iterations of this algorithm were performed
for each marker, and Z-scores computed as the difference between
the mean score under the null and the observed score, divided by
the null standard deviation. P-values were estimated by reference
to a standard normal distribution, and empirical p-values
computed as the number of times a randomly-generated test
statistic exceeded each observed value.
Table 1. Demographic Characteristics of Study Subjects.
Affected Affected with Typed Relative
Age Male Female Male Female Total
86–89 36 5 27 5 32
90–92 65 60 51 49 100
93–95 65 53 50 41 91
96–97 43 21 31 16 47
98–99 19 18 7 13 20
100+ 19 29 14 21 35
Total 247 186 180 145 325
Typed Affected Relative Pairs
Degree Total Closest
1st (sibs) 63 95
2nd 2 4
3rd 32 27
4th 27 25
5th 77 47
6th 93 27
7th 107 31
8th or more 206 69
Total 607 325
Relative Pairs: ‘‘Total’’ is a count of all pairs of a given type among genotyped affected individuals. ‘‘Closest’’ is a tabulation of the closest genotyped affected relative
among all genotyped affected individuals.
doi:10.1371/journal.pone.0034746.t001
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variation of the APM statistic [32]. The multipoint statistic is
simply the sum of Sij for a set of adjacent markers, but the
appropriate null distribution must then account for non-indepen-
dence among markers. To accommodate this requirement, the
gene-dropping algorithm (above) was modified so that ‘‘chromo-
somes’’ – sets of linked markers– passed from parents to offspring
with between-marker recombination probabilities assigned by
Haldane’s mapping function [33]. We simulated 500 null values
per chromosome. Z scores and p-values were computed as
described above. Multipoint APM (MAPM) scores were also
computed for all pairs of markers adjacent to a locus on either side,
at 1 centimorgan (cM) intervals; the technique weights the
contribution of each marker inversely by the relative probability
of recombination with the adjoining locus.
To adjust for multiple comparisons, we refer to the distribution
of simulated Z-scores across all markers and multipoint intervals,
and compute the experiment-wise p-values as described by
Churchill and Doerge [34].
For selected regions that showed evidence of linkage in both the
HMS and FLAG data (3p and 18q), we generated meta-nominal
p-values following the method of Dempfle and Loesgen [35].
These p-values were adjusted for multiple comparisons by
reference to the quantiles of the simulated Z-score distribution
described above.
Results
Figure 1 shows p-values for linkage across the genome from the
APM scan. Table 2 lists 19 markers with unadjusted asymptotic p-
values,0.01. Table 3 lists 17 multipoint regions with multiple
comparison-adjusted p-values,1.0. The most noteworthy linkage
scores indicate regions of interest on chromosomes 3p24 and
18q22. In each of these two regions, markers adjacent to the one
giving the highest linkage signal, also show evidence of linkage.
The strongest linkage signal was observed at D3S3547, on
chromosome 3p24.1 @56.45 cM (or 30.1 Mb). D3S1266 and
D3S3547 are immediately adjacent to one another on 3p24.1, as
are D18S469 and D18S1161 on 18q22.3. Tables 2 and 3 also
show p-values adjusted for multiple comparisons, as quantiles of
the minimum simulated p-value observed at each locus. Alone,
none of these results achieves genome-wide significance after
adjusting for the number of hypotheses tested. The most
significant genome-wide result is the singlepoint estimate for
D3S3547 (adjusted p=0.09). The same approximate location (@
55 cM) yields a multipoint adjusted p of 0.20. The linked region
on 18q22-23 appears more significant by multipoint (@109 cM;
adjusted p=0.25) than by the singlepoint (adjusted p=0.59 for
D18S1161 @111.05 cM) method.
To assess the degree of sensitivity of the linkage signal on
chromosome 3 to the criteria we used to assign ELP ‘‘affection’’
status, we repeated the APM analysis and reassigned affected
individuals 3 ways, depending on their attained age: 100, 98, or 95
years (regardless of sex or family history). Results are shown in
Figure 2 where the highest peak corresponds to D3S3547
(56.45 cM), the same marker with the highest signal by the
original APM test and definition of ELP affected. Shifting the
criterion up for attained age and reassigning affection status
accordingly, yielded peaks for the same markers, although the
magnitude of each peak was considerably diminished. A similar
reduction in evidence for linkage on 3p with increasing affection
threshold was observed by Boyden and Kunkel [1]. The true
centenarians (attained age of 100 yrs) exhibited a second peak at
marker D3S3521 (64.35 cM), sufficiently close to the linked region
reported here to warrant further investigation. It should be noted
that increasing the attained age threshold for ELP substantially
reduced the number of individuals counted as affected, especially
among true centenarians (195 individuals, 67 related pairs aged
$95; 88 individuals, 13 related pairs aged $98; 49 individuals, 9
related pairs aged $100). Therefore, the added linkage peak effect
Figure 1. FLAG study linkage results for all autosomes. A) nominal singlepoint p-values; B) nominal multipoint p-values.
doi:10.1371/journal.pone.0034746.g001
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as a result of a decrease in sample size.
Discussion
One immediate result of the FLAG study scan is an
independent replication of Boyden and Kunkel’s finding of a
genetic linkage between excess longevity and a locus in the 3p22-
24 region in the HMS data. Figure 3 compares the HMS and
FLAG linked regions, based on Boyden and Kunkel’s Age
Category 4 (upper 2.5% of the 1900 birth cohort). Superficially,
the HMS linked region appears broader than the linked region we
have observed. This may be a consequence of design differences
between the FLAG and HMS studies: a sib pair analysis led to the
HMS result, while an analysis of a wide range of kin relationships
led to the FLAG result, for approximately the same total number
of pairs in each study. Our sample from UPDB’s large multiplex
families ensures greater variation in shared chromosomal segment
length, and shorter average segments, among relative pairs
contributing to linkage peaks. On the other hand, the microsat-
ellite markers used in this study are less precise markers of location
because the distance between them is much greater than for the
SNP panel used by Boyden and Kunkel [1]. To remedy this, we
are conducting fine mapping studies to more precisely define the
shape and location of the linkage signal within the 3p22-24 region.
Figure 3 also shows results obtained by combining HMS and
FLAG data, using the unweighted mean Z-score approach of
Dempfle and Loesgen [35]. The combined data yield a linkage p-
value of 1.005610
29 (corresponding to an adjusted p=0.008) at
55 cM on 3p. The combined data provide further support for
Boyden and Kunkel’s suggestive linkage peak at 9q31-34 for Age
Category 8 (upper 0.5% of the 1900 birth cohort). We did not
identify a peak in the same region from our data alone; however,
Table 2. Markers linked to exceptional longevity with nominal p-value,0.01.
Chromosome Marker Map Position (cM) Z
Asymptotic
p-val Adjusted p-value
1 D1S2667 20.36 2.84 0.00223 0.966
1 D1S2628 168.68 2.76 0.00288 0.976
3 D3S1297 5.05 2.35 0.00928 1.000
3 D3S1266 52.22 2.60 0.00469 0.998
3 D3S3547 56.45 4.19 0.00001 0.090
4 D4S1615 129.75 2.49 0.00634 1.000
5 D5S424 93.23 3.14 0.00085 0.752
7 D7S502 80.86 2.55 0.00545 1.000
8 D8S585 47.96 2.62 0.00438 0.996
8 D8S531 63.93 2.45 0.00705 1.000
8 D8S281 119.66 2.80 0.00254 0.970
10 D10S196 71.95 3.15 0.00082 0.740
15 D15S1507 68.15 2.67 0.00375 0.992
15 D15S216 75.09 2.41 0.00796 1.000
17 D17S1795 77.3 3.27 0.00054 0.626
18 D18S469 106.38 3.00 0.00137 0.890
18 D18S1161 111.05 3.30 0.00048 0.592
20 D20S432 49.66 2.57 0.00504 1.000
21 D21S1898 38.62 2.71 0.00338 0.988
Singlepoint scores per marker.
doi:10.1371/journal.pone.0034746.t002
Table 3. Multipoint linked regions with adjusted p-
value,1.0.
Chromosome
Low
(cM)
High
(cM) max(Z) min(p) Adjusted p-value
1 20 21 2.73 0.00315 1.00
1 167 171 2.86 0.00215 1.00
3 53 58 4.40 0.00001 0.20
4 130 131 2.40 0.00819 1.00
5 92 96 2.85 0.00217 1.00
7 81 81 2.38 0.00862 1.00
8 45 48 2.87 0.00207 1.00
8 64 65 2.43 0.00757 1.00
8 120 121 2.56 0.00530 1.00
10 72 72 2.99 0.00142 1.00
10 115 118 2.64 0.00421 1.00
15 65 68 2.75 0.00301 1.00
17 77 78 3.01 0.00133 1.00
18 82 83 2.42 0.00774 1.00
18 105 114 4.30 0.00001 0.25
20 50 50 2.40 0.00814 1.00
21 37 39 2.48 0.00658 1.00
doi:10.1371/journal.pone.0034746.t003
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34 peak is 1.27610
25 (adjusted p=0.37) at 127.8 cM.
There are other suggested points of overlap between our results
and the HMS study: their Age Category 10 (upper 0.2% of the
1900 birth cohort) suggests linkage to a region on chromosome 8q
(meta p-value of 3.4610
24 at 120 cM, corresponding to an
adjusted p-value of 0.96). They found a similar suggestion of
linkage to a region on 17q (meta- p-value of 7.3610
24, adjusted
p=0.996, at 77 cM). However, our results do not indicate support
for their chromosome 4 linkage peak, originally reported by Puca
et al. [13], for their chromosome 12 peak reported in newly-
enrolled HMS subjects, nor do the original HMS data show any
indication of linkage anywhere on chromosome 18.
Human longevity is an outcome downstream of many biological
processes, and it’s very likely that multiple genes influence the trait.
The FLAG study was designed to capture an extreme phenotype
in a particular population, and our linkage results might be
difficult to derive in other population settings. However, compared
to most GWAS designs, the FLAG and HMS studies have better
power to identify rare variants with large effects. While such
variants may not explain a large portion of variation in longevity in
a given population, they might very well help to identify important
mechanisms that regulate onset and/or rates of aging in general.
Figure 2. Comparison of singlepoint linkage results for chromosome 3 under varying definitions of affected status (nominal p-
values).
doi:10.1371/journal.pone.0034746.g002
Figure 3. Comparison of chromosome 3 linkage results reported here to that reported by Boyden and Kunkel [13] (nominal p-
values).
doi:10.1371/journal.pone.0034746.g003
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anatomy might respond variably to mechanisms of aging, so that
variation in aging among organs might suggest areas particularly
amenable to pharmacological intervention.
Genes in the consensus linked region of 3p22-24 are listed in
Table 4. The consensus region is the largest region for the
combined data with a meta- p-value,0.001. Note that this
definition narrows the region of interest more specifically to
cytogenetic band 3p23-24.1. Of particular interest on 3p24.1 are
EOMES, CMC1, and AZI2 because of their potential interactions
with mTOR/rapamycin [36], free radical production and
detoxification [37,38], and apoptosis [39,40], respectively. Anoth-
er gene of particular interest in the 3p region is TGFBR2 because it
is implicated in multiple disease etiologies [41,42]), but of the 27
genes in the same region, most have functions that are not fully
understood.
Our definition of familial longevity (elevated FEL) assumes a
dominant or additive model of inheritance. As a consequence, our
selection criteria for affected individuals (and their familial
relationship networks) are less sensitive for identifying potential
recessive traits than dominant or additive traits. The familial
recurrence pattern expected for a recessive trait (sib pairs scattered
throughout a pedigree), would in most cases result in higher than
expected FEL, particularly in the large sibships typical of the
UPDB. Nevertheless, our study has substantially less power to
identify loci with recessive effects on longevity: only 63 affected sib
pairs are informative with respect to recessively inherited factors;
while 607 pairs are potentially informative for dominant or
additive inheritance.
We have recently described patterns of gene expression that are
associated with human longevity and aging [43]; now we can try to
narrow the set of longevity-associated candidate variants at the 3p
locus by searching for markers (microsatellites or SNPs) in the
same 3p region that are associated with variation in gene
expression patterns that are also associated with longevity.
Although in principle this requires a complete set of GWAS data
for each expression quantitative trait locus (or eQTL) of interest,
several established data repositories for genome-wide eQTL
studies [44,45], should greatly simplify the process.
The FLAG study differs from the HMS and other studies of
exceptional longevity in several important respects. We ascer-
tained subjects on the basis of both familial longevity and personal
longevity, which increases the probability that subjects carry a
longevity-predisposing variant, but also increases the probability
that any such variant is not widely distributed in the population.
Our subjects were all of primarily Northern European ancestry,
and hence were genetically less diverse than would be optimal for
maximum generalizability of our results. We selected pairs of
individuals related to varying degree, sometimes distantly related,
which allowed us to identify a fairly large sample, but prevented us
from using the most powerful techniques of linkage analysis. That
we did not identify some linkage peaks previously reported by
Boyden and Kunkel [1] or Puca, et al. [13] might be the result of
relatively low power, allelic heterogeneity, and/or differences in
study design. Our observation of a linkage peak on 18q that is
clearly not present in the HMS data might similarly be the result of
any of those factors. Given the substantial differences between the
FLAG and HMS studies, and their limitations, it seems striking
that the 3p23-24.1 region was clearly identified in both. Moreover,
while our data do not quite replicate linkage peaks on 9q, 8q, and
17q, there is considerable support in both data sets for the
possibility that predisposing variants are present in those regions as
well.
It is likely that variants at many loci contribute to the heritability
of longevity in humans. Our independent replication of the 3p22-
24 linkage peak originally reported by Boyden and Kunkel [1]
should help focus the search for variants associated with longevity
in this relatively small region. Advances in DNA sequencing make
it practical to rapidly sequence the exons in the region, or the
entire region, and hence identify the variant(s) responsible for the
observed linkage signal. Other regions identified in one or both of
these studies also deserve further scrutiny.
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Table 4. Genes in 3p22-24 linked region.
Symbol Start Stop Entrez Name
NEK10 27232101 27385916 152110 NIMA (never in mitosis gene a)- related kinase 10
SLC4A7 27389218 27473249 9497 solute carrier family 4, sodium bicarbonate cotransporter, member 7
EOMES 27732890 27738789 8320 eomesodermin
CMC1 28258128 28336267 152100 COX assembly mitochondrial protein homolog (S. cerevisiae)
AZI2 28339090 28365579 64343 5-azacytidine induced 2
ZCWPW2 28406991 28541636 152098 zinc finger, CW type with PWWP domain 2
RBMS3 29297807 30026890 27303 RNA binding motif, single stranded interacting protein 3
TGFBR2 30622998 30710637 7048 transforming growth factor, beta receptor II (70/80 kDa)
GADL1 30742696 30911157 339896 glutamate decarboxylase-like 1
Start and stop positions are given relative to the Human March 2006 (NCBI36/hg18) assembly.
doi:10.1371/journal.pone.0034746.t004
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